Idiotope-Driven T-Cell/B-Cell Collaboration-Based T-Cell Epitope Prediction Using B-Cell Receptor Repertoire Sequences in Infectious Diseases.

B-cell T-cell epitope anti-idiotypic antibody antigen idiotope-driven T-B collaboration idiotype network molecular mimicry repertoire analysis

Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
17 05 2023
Historique:
received: 27 02 2023
revised: 11 05 2023
accepted: 15 05 2023
medline: 29 5 2023
pubmed: 27 5 2023
entrez: 27 5 2023
Statut: epublish

Résumé

T-cell recognition of antigen epitopes is a crucial step for the induction of adaptive immune responses, and the identification of such T-cell epitopes is, therefore, important for understanding diverse immune responses and controlling T-cell immunity. A number of bioinformatic tools exist that predict T-cell epitopes; however, many of these methods highly rely on evaluating conventional peptide presentation by major histocompatibility complex (MHC) molecules, but they ignore epitope sequences recognized by T-cell receptor (TCR). Immunogenic determinant idiotopes are present on the variable regions of immunoglobulin molecules expressed on and secreted by B-cells. In idiotope-driven T-cell/B-cell collaboration, B-cells present the idiotopes on MHC molecules for recognition by idiotope-specific T-cells. According to the idiotype network theory formulated by Niels Jerne, such idiotopes found on anti-idiotypic antibodies exhibit molecular mimicry of antigens. Here, by combining these concepts and defining the patterns of TCR-recognized epitope motifs (TREMs), we developed a T-cell epitope prediction method that identifies T-cell epitopes derived from antigen proteins by analyzing B-cell receptor (BCR) sequences. This method allowed us to identify T-cell epitopes that contain the same TREM patterns between BCR and viral antigen sequences in two different infectious diseases caused by dengue virus and SARS-CoV-2 infection. The identified epitopes were among the T-cell epitopes detected in previous studies, and T-cell stimulatory immunogenicity was confirmed. Thus, our data support this method as a powerful tool for the discovery of T-cell epitopes from BCR sequences.

Identifiants

pubmed: 37243272
pii: v15051186
doi: 10.3390/v15051186
pmc: PMC10221809
pii:
doi:

Substances chimiques

Epitopes, T-Lymphocyte 0
Epitopes, B-Lymphocyte 0
Receptors, Antigen, T-Cell 0
Receptors, Antigen, B-Cell 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Nature. 1983 Apr 14;302(5909):575-81
pubmed: 6300689
Blood. 2003 Jun 15;101(12):4930-6
pubmed: 12576325
Scand J Immunol. 2009 Dec;70(6):526-30
pubmed: 19906193
Emerg Infect Dis. 2020 Jul;26(7):1624-1626
pubmed: 32240079
Front Immunol. 2021 Sep 15;12:712488
pubmed: 34603286
Ann Immunol (Paris). 1974 Jan;125C(1-2):373-89
pubmed: 4142565
Tissue Antigens. 2012 Oct;80(4):305-16
pubmed: 22861646
J Immunol. 1990 Mar 1;144(5):1625-8
pubmed: 1689751
J Immunol. 2004 Jun 15;172(12):7476-84
pubmed: 15187126
Front Immunol. 2017 May 03;8:389
pubmed: 28515723
N Engl J Med. 2022 Jan 27;386(4):394-396
pubmed: 34818473
Nucleic Acids Res. 2021 Jan 8;49(D1):D916-D923
pubmed: 33270111
Nucleic Acids Res. 2014 Jan;42(Database issue):D660-5
pubmed: 24304891
Trop Med Health. 2022 Jan 4;50(1):3
pubmed: 34983690
Viruses. 2012 Sep;4(9):1438-76
pubmed: 23170167
Front Oncol. 2012 Dec 19;2:196
pubmed: 23267437
Annu Rev Immunol. 2020 Apr 26;38:123-145
pubmed: 32045313
BMC Genomics. 2015 Apr 18;16:318
pubmed: 25895492
Curr Microbiol. 2021 Jan;78(1):17-32
pubmed: 33231723
Nat Rev Immunol. 2014 Jun;14(6):377-91
pubmed: 24830344
China CDC Wkly. 2021 Dec 3;3(49):1049-1051
pubmed: 34934514
Lupus. 1995 Dec;4(6):464-71
pubmed: 8749569
Trends Immunol. 2010 Feb;31(2):56-62
pubmed: 19962346
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Int J Environ Res Public Health. 2021 Sep 18;18(18):
pubmed: 34574767
Transl Med Commun. 2021;6(1):18
pubmed: 34458584
Front Oncol. 2012 Nov 09;2:159
pubmed: 23162790
Biomed Rep. 2020 May;12(5):244-250
pubmed: 32257187
Nat Immunol. 2023 Apr;24(4):604-611
pubmed: 36879067
Nat Rev Immunol. 2004 Apr;4(4):308-12
pubmed: 15057789
Nat Med. 2000 Jun;6(6):667-72
pubmed: 10835683
Nucleic Acids Res. 2017 Jul 3;45(W1):W24-W29
pubmed: 28472356
Science. 2020 Oct 2;370(6512):89-94
pubmed: 32753554
Nature. 2017 Mar 30;543(7647):723-727
pubmed: 28329770
PLoS One. 2021 Sep 3;16(9):e0257016
pubmed: 34478478
Front Immunol. 2014 Oct 28;5:541
pubmed: 25389426
PLoS Comput Biol. 2012;8(3):e1002412
pubmed: 22396638
Allergy. 2020 Jul;75(7):1564-1581
pubmed: 32396996
Immunology. 2018 Jul;154(3):394-406
pubmed: 29315598
Nucleic Acids Res. 2019 Jan 8;47(D1):D339-D343
pubmed: 30357391
Viral Immunol. 2010 Jun;23(3):259-84
pubmed: 20565291
Eur J Immunol. 1999 Dec;29(12):4043-52
pubmed: 10602015
FASEB J. 1993 Mar;7(5):437-44
pubmed: 8462785
Cells. 2012 Jul 25;1(3):313-24
pubmed: 24710478
Protein Sci. 2022 Jan;31(1):173-186
pubmed: 34664328
Int J Mol Sci. 2021 Mar 22;22(6):
pubmed: 33809918
J Immunol. 2017 Nov 1;199(9):3360-3368
pubmed: 28978689
Immunol Rev. 1998 Apr;162:233-46
pubmed: 9602368
J Exp Med. 1983 Dec 1;158(6):2183-8
pubmed: 6227679
J Exp Med. 2004 Jul 5;200(1):1-11
pubmed: 15226360
Hum Vaccin Immunother. 2013 Jul;9(7):1577-86
pubmed: 23584251
Nucleic Acids Res. 2005 Jan 1;33(Database issue):D256-61
pubmed: 15608191
Proc Natl Acad Sci U S A. 1989 Jan;86(1):282-6
pubmed: 2492101
Front Immunol. 2015 Oct 22;6:538
pubmed: 26557118
Annu Rev Immunol. 2006;24:419-66
pubmed: 16551255
Proc Natl Acad Sci U S A. 2019 Dec 17;116(51):25850-25859
pubmed: 31796587
Adv Drug Deliv Rev. 2021 Apr;171:29-47
pubmed: 33465451

Auteurs

Yukio Nakamura (Y)

Repertoire Genesis Inc., Osaka 567-0085, Japan.

Meng Ling Moi (ML)

Department of Developmental Medical Sciences, Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan.

Takashi Shiina (T)

Department of Molecular Life Science, Tokai University School of Medicine, Kanagawa 259-1193, Japan.

Tadasu Shin-I (T)

BITS Co., Ltd., Tokyo 101-0062, Japan.

Ryuji Suzuki (R)

Repertoire Genesis Inc., Osaka 567-0085, Japan.
Department of Rheumatology and Clinical Immunology, Clinical Research Center for Rheumatology and Allergy, National Hospital Organization Sagamihara National Hospital, Kanagawa 252-0392, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH